IL1R1 and depressive symptom measurement: To assess whether cytokine signaling blockade could attenuate C3 release and the behavioral deficits in depression-like animals, Anakinra, an IL-1R antagonist was administered daily for 4 consecutive weeks in mice exposed to CUMS.